Notably, the protein level of XRCC2 and XRCC9 were found to be overexpressed in normal ovarian tissues, whereas XRCC4 was highly expressed in patients with ovarian carcinoma, which was consistent with the prognosis of ovarian cancer. The gene discussed is XRCC2; the disease is ovarian carcinoma.